Rigorous detection and vigorous treatment of familial hypercholesterolaemia
- 1 February 2001
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 357 (9256) , 574-575
- https://doi.org/10.1016/s0140-6736(00)04075-7
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Review of first 5 years of screening for familial hypercholesterolaemia in the NetherlandsThe Lancet, 2001
- Outcome of case finding among relatives of patients with known heterozygous familialBMJ, 2000
- Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatinAtherosclerosis, 2000
- Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.Health Technology Assessment, 2000
- Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical managementAtherosclerosis, 1999
- Cholesterol Lowering With Statin Drugs, Risk of Stroke, and Total MortalityJAMA, 1997
- Stability and Instability: Two Faces of Coronary AtherosclerosisCirculation, 1996
- Rapid screening for specific mutations in patients with a clinical diagnosis of familial hypercholesterolaemiaAtherosclerosis, 1991
- A CONTRIBUTION TO THE STUDY OF THE ETIOLOGY OF XANTHOMA MULTIPLEXArchives of Dermatology and Syphilology, 1920